Taro Kakikawa

Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes.

P. Stein, M. Davies, A. Sato, 2008, Diabetes research and clinical practice.

Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study

T. Tomomitsu, M. Fukunaga, Y. Ohashi, 2005, Journal of Bone and Mineral Metabolism.

Lipid-modifying efficacy and tolerability of anacetrapib added to ongoing statin therapy in Japanese patients with dyslipidemia.

H. Daida, H. Arai, T. Teramoto, 2017, Atherosclerosis.